Related Experiment Videos
Leukaemia in the young child
1Department of Haematology and Oncology, Hospital for Sick Children, London, UK.
The British Journal of Cancer. Supplement
|August 1, 1992
Summary
Leukemia in infants presents unique challenges, with distinct characteristics and poorer prognoses for acute lymphoblastic leukemia (ALL) under one year. Management of leukemia in children under two remains a significant clinical challenge.
Area of Science:
- Pediatric Oncology
- Hematology
Background:
- Leukemia is rare in infancy, with a near-equal distribution of lymphoblastic and myeloblastic types.
- Infant acute lymphoblastic leukemia (ALL) under one year often presents with high leukocyte counts, organomegaly, and specific B-cell phenotypes, associated with a poor prognosis.
Purpose of the Study:
- To review the characteristics and management of leukemia in infants and young children.
- To highlight the differences between infant ALL, childhood ALL, and acute myeloid leukemia (AML) in children.
Main Methods:
- Review of existing literature on infant and childhood leukemia.
- Analysis of clinical characteristics, treatment responses, and prognostic factors.
Main Results:
- Infant ALL under one year has distinct features and a poor prognosis.
- Toddlers (1-2 years) often develop typical childhood ALL, responsive to treatment but with risks of late effects.
- Acute myeloid leukemia (AML) subtypes vary by age, with improved treatment outcomes across pediatric groups.
Conclusions:
- Different genetic and environmental factors likely contribute to the genesis of infant ALL, childhood ALL, and pediatric AML.
- A unified management strategy for childhood AML is desirable.
- Leukemia management in children under two years presents considerable challenges.